# SBNO2

## Overview
SBNO2 is a gene that encodes the protein strawberry notch homolog 2, a member of the DExD/H-box helicase family. This protein is characterized by its ATP-dependent RNA helicase activity, which plays a crucial role in various cellular processes, including transcription regulation, mRNA splicing, RNA stability, and RNA metabolism (Aschenbrenner2024An). The protein is primarily localized in the nucleus, where it functions as a transcriptional regulator, modulating the dissociation of transcriptional regulators from the genome and impacting gene expression (Syme2022Strawberry). SBNO2 is involved in immune responses, particularly in the regulation of inflammatory pathways, and has been implicated in conditions such as Crohn's disease and osteoporosis due to its role in antimicrobial activity and bone health (Aschenbrenner2024An). The gene's expression is responsive to cytokines like interleukin-10 and lipopolysaccharide, highlighting its significance in immune cell function and signaling pathways (Aschenbrenner2024An).

## Structure
The SBNO2 gene encodes a protein that is part of the DExD/H helicase family, characterized by a DExD/H-box group and a helicase C-terminal domain, which are crucial for its ATP-dependent RNA helicase activity (Aschenbrenner2024An). This protein is involved in various cellular processes, including transcription regulation, mRNA splicing, RNA stability, and RNA metabolism (Aschenbrenner2024An). 

SBNO2 has two main isoforms, ISO1 and ISO2, which differ structurally. Both isoforms contain conserved helicase-C and ATPase domains, but ISO2 lacks certain exons at its 5' end, resulting in a shorter C-terminal end (Aschenbrenner2024An). These isoforms are evolutionarily conserved across species such as mice, rats, zebrafish, and drosophila, indicating their functional importance (Aschenbrenner2024An).

The protein's structure does not include a clear sequence-specific DNA-binding domain, suggesting that its target gene specificity might be conferred by the transcription factors it interacts with (Syme2022Strawberry). SBNO2 is primarily localized in the nucleus, where it likely modulates the dissociation of transcriptional regulators from the genome, impacting gene expression (Syme2022Strawberry).

## Function
The SBNO2 gene encodes a protein that functions as a transcriptional regulator, primarily active in the nucleus of cells. It is involved in various molecular processes, including transcription, mRNA splicing, RNA stability, and RNA metabolism. SBNO2 may exert its regulatory effects by interacting with transcriptional activators and repressors, influencing gene expression through these interactions (Aschenbrenner2024An).

In healthy human cells, SBNO2 plays a crucial role in modulating inflammatory responses. It is particularly responsive to cytokines such as interleukin-10 (IL-10) and lipopolysaccharide (LPS), which differentially regulate its isoforms. The gene's expression is notably increased in immune cells, such as monocyte-derived dendritic cells, upon activation with TLR-ligands (Aschenbrenner2024An). SBNO2 is also involved in the regulation of myeloid antimicrobial activity, influencing ATPase function and lysosome maturation, which are essential for effective microbial recognition and inflammatory responses (Aschenbrenner2024An).

SBNO2's role extends to bone health, where it influences osteoclast differentiation and bone mineral density. Genetic variations in SBNO2 are associated with susceptibility to conditions like Crohn's disease and osteoporosis, highlighting its importance in maintaining normal immune and bone functions (Aschenbrenner2024An).

## Clinical Significance
Mutations and alterations in the SBNO2 gene have been linked to several diseases and conditions. In the context of Crohn's disease, genetic variations at the SBNO2 locus are associated with decreased expression of the SBNO2 ISO2 isoform, which is crucial for antimicrobial activity in macrophages. This reduction in expression is linked to increased susceptibility to Crohn's disease due to impaired antimicrobial responses and intestinal inflammation (Aschenbrenner2024An). 

SBNO2 is also implicated in bone health, with variants near the SBNO2 ISO1 transcription start site affecting bone mineral density. This association suggests a potential link to osteoporosis, particularly in male patients with ankylosing spondylitis, where SBNO2 expression is correlated with osteoclast differentiation and bone metabolism (Aschenbrenner2024An; Li2020Genderspecific).

In the central nervous system, SBNO2 acts as a negative feedback regulator of interleukin-6 (IL-6) signaling. Its absence exacerbates neuroinflammation and neurodegeneration, indicating its role in modulating inflammatory responses in diseases such as schizophrenia, Alzheimer's disease, and stroke (Syme2022Strawberry). These findings highlight the clinical significance of SBNO2 in inflammatory and bone-related disorders.

## Interactions
SBNO2, a member of the strawberry notch family of nuclear helicases, is involved in transcriptional regulation within the central nervous system. It acts as a feedback transcriptional repressor in response to interleukin-6 (IL-6) signaling. SBNO2 does not increase IL-6 cytokine levels or signal pathway activation but modulates the dissociation of transcriptional regulators from the genome, suggesting it may remove activating transcription factors to dampen the expression of IL-6-stimulated genes (Syme2022Strawberry). 

In the context of IL-6 signaling, SBNO2 is hypothesized to interact with transcriptional regulators and chromatin remodeling factors, although specific protein interactions remain unclear (Syme2022Strawberry). The study by Syme et al. explored potential interactions with NF-κB, but phosphorylation of NF-κB was undetectable across all genotypes, leaving the exact protein interactions of SBNO2 unresolved (Syme2022Strawberry). 

While the precise molecular interactions of SBNO2 are not fully detailed, its role as a nuclear-localized regulator of IL-6 signaling and its involvement in modulating transcriptional responses highlight its significance in cellular signaling pathways (Syme2022Strawberry).


## References


[1. (Syme2022Strawberry) Taylor E. Syme, Magdalena Grill, Emina Hayashida, Barney Viengkhou, Iain L. Campbell, and Markus J. Hofer. Strawberry notch homolog 2 regulates the response to interleukin-6 in the central nervous system. Journal of Neuroinflammation, May 2022. URL: http://dx.doi.org/10.1186/s12974-022-02475-1, doi:10.1186/s12974-022-02475-1. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12974-022-02475-1)

[2. (Aschenbrenner2024An) Dominik Aschenbrenner, Isar Nassiri, Suresh Venkateswaran, Sumeet Pandey, Matthew Page, Lauren Drowley, Martin Armstrong, Subra Kugathasan, Benjamin Fairfax, and Holm H. Uhlig. An isoform quantitative trait locus in sbno2 links genetic susceptibility to crohn’s disease with defective antimicrobial activity. Nature Communications, May 2024. URL: http://dx.doi.org/10.1038/s41467-024-47218-3, doi:10.1038/s41467-024-47218-3. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-47218-3)

[3. (Li2020Genderspecific) T. Li, W.-B. Liu, F.-F. Tian, J.-J. Jiang, Q. Wang, F.-Q. Hu, W.-H. Hu, and X.-S. Zhang. Gender-specific sbno2 and vps13b as a potential driver of osteoporosis development in male ankylosing spondylitis. Osteoporosis International, 32(2):311–320, August 2020. URL: http://dx.doi.org/10.1007/s00198-020-05593-9, doi:10.1007/s00198-020-05593-9. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00198-020-05593-9)